Moon-hee Yum

Recapturing disease response: A phase 2 study of carfilzomib 56 mg/m2 in patients with relapsed or refractory multiple myeloma who have progressed on carfilzomib 27 mg/m2

S. Jagannath, D. Madduri, S. Parekh, 2019, American journal of hematology.

A Phase II Study of Panobinostat with Lenalidomide and Weekly Dexamethasone in Myeloma

A. Laganà, S. Jagannath, Manishkumar Patel, 2015 .

A Phase II, Single-Center, Open-Label Study Of Oral Panobinostat In Combination With Lenalidomide and Weekly Dexamethasone In Patients With Multiple Myeloma

S. Jagannath, S. Parekh, A. Chari, 2013 .